As more drugs go subcutaneous, Phillips Medisize's director of Front-End Innovation, Tony Bedford, believes that high-dose biologics will become a prevalent choice for drugmakers.
Injectable dermal products have become some of the most sought-after cosmetic treatments. But behind every injection lies a complex combination of materials that determines how these products behave ...
In the early 1990s, Keith Willmott and a friend, both undergraduate students from the United Kingdom, arrived in Ecuador with ...